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COMPARATIVE STUDY OF HEMATOXYLIN & EOSIN, SPECIAL 
STAINS AND IMMUNOHISTOCHEMISTRY FOR DETECTION OF 
HELICOBACTER PYLORI IN BOTH NEOPLASTIC AND 
NON-NEOPLASTIC GASTRIC LESIONS 
 
ABSTRACT 
 
Aims and Objectives : The role of Helicobacter Pylori in the pathogenesis of 
Gastritis-Peptic ulcer syndrome and its association with the development of 
upper gastrointestinal tract malignancy warrant efficient method for the 
identification of the bacteria in biopsy specimens. Four staining methods - 
Hematoxylin and Eosin, Giemsa, Toluidine Blue and Immunohistochemistry 
were compared to detect the presence of Helicobacter pylori. The prevalence of 
H.Pylori in gastric biopsies was also evaluated. 
 
Methods : A total of 70 cases (40 cases of gastritis and 30 cases of gastric 
adenocarcinoma) were randomly selected for this study and all the four stains 
were applied. 
 
Results : Helicobacter pylori infection showed an overall prevalence rate of 
about 67.1%. When compared with Immunohistochemistry, Sensitivity and 
specificity of Hematoxylin and Eosin was 57.45% and 100% respectively. 
Giemsa showed sensitivity of about 87.23% and specificity of about 100%. 
Toluidine blue showed sensitivity of about 78.72% and specificity of about 
100%. 
 
Conclusion : Hence in the present study Giemsa was more reliable and cost 
effective stain when compared with Hematoxylin & Eosin, Toluidine blue and 
immunohistochemistry. However, Immunohistochemistry carries the highest 
level of sensitivity in the detection of Helicobacter Pylori especially when the 
density of organism is low and in clinically suspected cases of Helicobacter 
Pylori with negative Giemsa staining 
 
Key Words : Helicobacter pylori, Hematoxylin & Eosin, Giemsa, Toluidine 
blue, Immunohistochemistry. 
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INTRODUCTION  
 
Helicobacter pylori plays an important role in the causation of 
numerous benign, premalignant and malignant lesions of Gastrointestinal 
tract which include peptic ulcer, gastritis, intestinal metaplasia, gastric 
adenocarcinoma and Mucosa – associated lymphoid tissue lymphoma.[1] 
 
H.pylori is a Gram-negative bacteria which has a spiral shape and 
affects more than 50% of individuals in developed countries and in 
developing countries it involves more than 90% of population .   
Numerous methods are available for the diagnosis of H.pylori[1,2].  
They are classified into 2 groups. 
 
(1) Non invasive methods – which include urea breath test, 
serology and fecal antigen test. 
 
(2) Invasive methods – include rapid urease test, Polymerase Chain 
Reaction, histopathological examination and culture.  
Histopathological examination remains the gold standard for 
the identification of H.pylori because it is possible to identify 
various pathogenic changes associated with this infection such 
as inflammation, intestinal metaplasia, atrophy and malignancy 
[1, 2]. 
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In 1994 (WHO) World Health Organisation and the International 
Agency for Research on Cancer (IARC) classified H.pylori infection as a 
group I carcinogen in humans [3]. 
 
The updated Sydney system graded gastritis based on several 
parameters which includes inflammation, activity, intestinal metaplasia, 
atrophy and density of H.pylori [4]. 
 
 Several histochemical stains are available for detecting the presence 
of H.pylori in gastric biopsies and resection specimens which include 
Hematoxylin and Eosin (H&E), toluidine blue, modified Giemsa, Alcian 
yellow – toluidine blue, Warthin-starry, modified Genta and Immuno 
histochemistry staining.  H&E and Giemsa are more commonly used. 
Several studies have been conducted about the need for use of special stains 
and immunohistochemistry in H.pylori detection [5]. 
 
 The aim of the present study is to compare the efficacy of 
Hematoxylin and Eosin, Giemsa , toluidine blue and immunohistochemistry 
for the detection of H.pylori in cases of  gastritis and gastric 
adenocarcinoma. 
 
 
 
 
 
Aims and Objectives 
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AIMS AND OBJECTIVES 
 
1) To evaluate the prevalence of H.Pylori in non-neoplastic and 
neoplastic gastric lesions. 
 
2) Comparing the efficacy of Hematoxylin & Eosin, Special stains 
(Giemsa, Toluidine blue) & Immunohistochemistry for detection of 
Helicobacter pylori in non-neoplastic and neoplastic gastric lesions. 
 
 
 
 
 
 
Review of Literature 
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REVIEW OF LITERATURE 
 
EMBRYOLOGY 
 
 The stomach is a derivative of primitive foregut which is seen as a 
fusiform dilatation. During the late 5th week of gestation, the stomach 
rotates about 90 degree along its longitudinal axis. This results in a position, 
that right side faces backwards and left side faces the front. During that 
period of rotation, there is rapid growth of posterior wall than the anterior 
which results in the formation of greater and lesser curvatures [6]. 
 
 During the early stages the stomach is located in the midline. Later, 
there is mobilisation of caudal portion towards up and to right side 
becoming the antropyloric region. The cephalic portion undergoes rotation 
to the left and slightly downward forming cardia[ 6].  
 
ANATOMY 
 Grossly the stomach consists of the following regions. 
 
• Cardia – seen just distal to the gastroesophageal junction which is 
narrow and  conical shaped.  
 
• Fundus – It is the dome shaped portion of the stomach situated 
proximally. 
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• Body or corpus – It forms the portion of stomach situated proximal to 
incisura angularis. 
• Antrum – Occupies the portion of stomach distal to incisura 
angularis. 
• Pylorus – The narrowest portion of the stomach situated most distally. 
 
 Lesser curvature forms the superomedial margin and greater 
curvature forms the inferolateral margin.  On the serosal side the junction 
between the antrum and corpus  is noted by a notch called incisura seen in 
the lesser curvature.  The mucosa is thrown into numerous folds termed as 
rugae. 
 
MICROSCOPY [7]: 
 The mucosa of the body of stomach has an appearance of ‘Moracco 
leather’ under dissecting microscope because of uniform, closely packed  
regular papillae and at the apex of each has a circular opening of gastric 
gland. 
 
 The mucosa of the antrum has a coarser leaf-like pattern formed by 
the aggregation of numerous papillae which form each leaf . In scanning 
electron microscopy the mucosa of the body of stomach has a ‘cobblestone’ 
pattern [8]. 
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The (foveolar) surface epithelium : 
 It is present uniformly throughout the stomach .  It has a single layer 
of  cells which are tall columnar  with the nuclei basally located and secretes 
mucus.  This epithelium lines the gastric pits and surface papillae. 
 
Each cell shows the presence of microvilli on their luminal aspect 
which are small and pleomorphic of about 0.05 – 0.15 µm in diameter and 
0.2 – 0.6 µm high.  There is also a glycocalyceal coat [9]. 
 
The Cardiac Zone : 
 It is seen as a downward extension from the cardio-esophageal 
junction of about 5 – 30mm [10].  The mucosa of the cardia is called as 
junctional mucosa because it represents the anatomical boundary between 
stomach and esophagus.  The glands of the cardia are usually branched , 
tubular and are separated by elongation of muscularis  mucosae and by 
connective tissue  [11].  The glands also show cystic dilatation and the 
deeper part of the mucosa shows the presence of lymphoid follicles.  
Endocrine cells and acid secreting cells are present few in number. 
 
The body and fundus : 
 The superficial zone formed by gastric crypts which are lined by 
surface epithelium constitutes 25% of total mucosal thickness.  The deeper 
zone is composed of straight tubules which are seen perpendicular to the 
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surface form the rest of 75% thickness.  At the bottom of each crypt there is 
a constriction or neck where the glands open.  The body of the stomach 
shows the presence of four types of cells – the parietal or Oxyntic cells, 
mucous neck cells, endocrine cells and chief or zymogenic cells [10,12]. 
 
Mucous neck cells : 
 These cells are mainly seen in the upper portion of tubules.  They are 
low columnar and more triangular when compared to the surface epithelial 
cells which are high columnar in shape.  These cells contain neutral mucin . 
 
 Some studies consider mucous neck cells as transitional cells, in 
gastric stem cells differentiation to chief or zymogen cells [13,14]. Mucous 
neck cells also play a role in the protection of gastric mucosa against gastric 
acid secretion  by their production of numerous luminally active peptides. 
 
Parietal, oxyntic cell / Acid secreting cells[7] 
 These cells line the upper portion of glands seen in the mucosa of the 
body of stomach.  These cells secrete intrinsic factor , hydrochloric acid and 
blood group substances .  The cells are round, large or pyramidal in shape, 
having eosinophilic or vacuolated cytoplasm and a central nucleus. 
 
Pepsinogen – Secreting (Chief) Cells : 
 These cells line the deeper portion of the tubules and are more near 
the cardiac end of body mucosa .  These cells are low columnar or cuboidal 
8 
 
and have neutrophilic cytoplasm.  Pepsinogens I and II [15] and proteolytic 
proenzymes like lipase  are produced by these cells. 
 
Endocrine cells : 
 These cells are widely distributed in all portions of the stomach  and 
are seen as clear round or halo cells between the epithelium and the 
glandular basement membrane.  Enterochromaffin or argentaffin cells 
contain Serotonin.  D cells are seen in the antrum and body which produces 
somatostatin. 
 
 Gastrin is produced by the G cells which are seen mostly in the 
middle and lower third mucosa of antropyloric region whose density 
decreases from pylorus to the body of stomach [16]. 
 
The antral and pyloric region : 
 The antral mucosa thickness varies from 200 to 1100 µm of which 
40% is contributed by the surface pits.  They show branching and are not  
perpendicular to the surface.  The deeper zone is formed by coiled tubules 
with few show branching.  The lining consists of mucin secreting cells 
which are faintly granular and the nucleus is basally located. 
 
 Pyloric mucosa contains occasional parietal cells and their number 
increases towards the gastroduodenal junction [17]. 
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The Intermediate Zone : 
 In this zone, half of the mucosal thickness is occupied by the pits and 
shows the presence of both pyloric and cardiac glands. 
 
Lamina propria : 
 It is formed by connective tissue network which contains lymphatics, 
blood vessels, cells of macrophage and immune system and nerve fibrils.  
Immunoglobulin A (IgA) containing plasma cells are seen more in the antral 
region [18]. 
 
Muscularis Mucosae : 
 The thickness of muscularis mucosae varies from 30 to 210 µm and 
does not show inflammatory cells normally.  
 
Submucosa : 
 This is formed by loose connective tissue, scant adipose tissue and 
contains blood vessels ,lymphatics and ganglion cells. 
 
Muscle Coats : 
 The stomach consists of three muscle coats.  The inner circular layer 
covers the entire stomach and lies in continuation with that of esophagus.  
The outer longitudinal layer extends from esophagus to the duodenum.  
Oblique fibres which lie internal to the circular layer extend down from 
cardia and run parallel to lesser curve. At the pylorus the circular muscle 
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layer undergoes thickening which leads to the formation of proximal and 
distal loops that unite along the lesser curve [19,20] in a complex or torus. 
 
Serosa : 
 This lies in continuity with the peritoneum and formed by loose 
areolar tissue in which lies blood vessels, lymphatics, ,nerve fibres and lined 
by flattened mesothelial cells. 
 
DISCOVERY OF H.PYLORI [21] 
 In 1979, a pathologist RobinWarren, identified the presence of curved 
bacteria in gastric biopsies which were submitted for histopathological 
examination. These curved bacteria were seen in the surface mucus layer 
[22]. 
 
 Barry Marshall and Warren isolated these organisms from biopsy 
specimens by inoculating them onto selective media and under microaerobic 
conditions the culture was incubated. After an incubation period of 5 days 
these colonies were identified [23] and named as campylobacter pyloridis. 
 
 After that, several investigations had confirmed the presence of 
H.pylori in the gastric mucus [24,25]. 
 
 Marshall and Warren found the association between H.pylori 
infection and duodenal ulceration [23]. 
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 In 1994, it was proved in National Institute of Health Conference that 
H.pylori was the main etiological factor for peptic ulcer and the affected 
patients were recommended for treatment to eradicate H.pylori [26]. 
 
 The association between H.pylori and gastric cancer was proved in 
1991 [27,28]. 
 
 In 1994, H.pylori was declared as a human carcinogen [29] by the 
International agency for cancer research. 
 
                                   MORPHOLOGY [21] 
             H.pylori is a microaerophilic, gram negative bacteria which is spiral 
shaped. In gastric biopsies they usually show blunt rounded ends [30]. 
H.pylori usually reveals a rod-like shape on culture with solid medium . 
Coccoid forms usually predominate in solid or liquid culture medium after 
prolonged incubation period [31].  Coccoid forms are seen as U-shaped 
structures on electron microscopy and a membranous structure usually 
connects the ends of both arms.  H.pylori organisms are about 2.5 to 5.0 µm 
in length and width of about 0.5 to 1.0 µm.  These organisms show four to 
six unipolar sheathed flagellae which helps in mobility.  Each flagellum is 
about 2.5 mm thick and approximately 30 µm in length [32]. 
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EPIDEMIOLOGY[33] 
 
 Several studies  showed that the prevalence of infection with H.pylori 
is more common in developing countries when compared to that of 
developed countries.[34,35] 
 
 The prevalence rate also varies according to age, sex, race, 
geographic area, and socioeconomic status . In a study conducted at China, 
among 98 children it was found that more than 70% of children aged 5-6 
years showed infection with H.pylori [36]. Similar infection rates were also 
seen in adults of that region [37]. This study revealed that most cases of 
H.pylori infection occur in early childhood life. 
 
 The prevalence of H.pylori is usually more in developing countries 
with a prevalence rate of 70% when compared to developed countries where 
the prevalence rate is about 40%. 
 
 In developed countries, the adult individuals show a low annual rate 
of seroconversion of about 0.2 – 1.0% . 
 
 Good sanitation and better hygiene are usually associated with low 
incidence of H.pylori infection in developed countries. 
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 In a study conducted at United States, it was evident that H.pylori 
showed difference in distribution among various races. Whites showed 
lower seroprevalence of infection with H.pylori when compared to Blacks 
and Hispanics [38]. 
 
 Another study at NewZealand [64] also showed the presence of ethnic 
differences in patients with H.pylori infection. It was more  
common in pacific islands, least common in Europeans and intermediate in 
Maori. 
 
 The variations in H.pylori prevalence among different races and 
ethinicity are commonly linked with difference in hygienic practices, socio 
economic status, or extensive antimicrobial usage during childhood for the 
treatment of common infections[39]. 
 
 In a study conducted at United States, it was found that poverty, 
overcrowding, poor hygiene, residence at rural areas and lack of education 
were commonly associated with H.pylori infection. 
 
 In a study by Graham et al 1991 [40] at Texas it was evident that 
there was difference in distribution of H.pylori infection among blacks and 
whites races. Among 246 blacks 70% showed positivity for H.pylori by 
serology and among 239 whites 34% showed positivity. 
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 In a study conducted at Bangladesh by Ahmad et al 1997 [41] it was 
found that among 181 outpatients in the age group of 20-44 years 92% 
showed positivity for H.pylori by serology. 
 
RISK FACTORS [33] 
Smoking : 
 The possibility of association between smoking and H.pylori 
infection has been assessed by several studies. Some studies showed that 
H.pylori seropositive individuals were mostly found to be current smokers 
[42,46] when compared with seronegative persons. 
 
 Many recent studies showed that the association of current smoking 
or tobacco use with H.pylori infection had no significance. [37,43,44,45]. 
 
Alcohol 
 Several epidemiological studies showed that there was no significant 
association seen between H.pylori infection and consumption of alcohol but 
many studies showed a nonstatistically significant rate of reduction in risk 
[43,44,45,46]. 
 
 Alcohol consumption causes pH reduction resulting in an acidic 
environment of the stomach which favoures the survival of H.pylori . 
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Diet 
 Several studies have found the association between H.pylori and 
consumption of diet. 
 
 Fontham et al [46] and Goodman et al [47,48] found that there was 
low risk of infection with H.pylori in individuals who consume large 
amount of fruits and vegetables. 
 
 Goodman et al [47] found that high levels of beta-carotene had a 
protective role against H.pylori. 
 
 Jarojz et al [49] in his study showed that in chronic gastritis patients, 
after 4 weeks of treatment with Vitamin C, H.pylori was eradicated in 30% 
of individuals. 
 
 Begue et al [50] in his study at Peru stated that there was increased 
risk of H.pylori infection among individuals who consumed food from street 
vendors due to poor sanitary conditions. 
 
Occupational Exposures 
 Lin et al [51] in his study found that the prevalence of infection with 
H.pylori was significantly higher in endoscopists (80%) when compared 
with dentists (21%). 
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 The increased risk among endoscopists than dentists suggests that in 
H.pylori transmission, gastric mucus serves as a better medium for 
transmission than saliva [52]. 
 
Waterborne exposures: 
 Several studies in rural China, Colombia and LimePeru [37,48] 
revealed the possibility of  association seen between water source and risk 
of infection with H.pylori.  
 
 Zhang et al [37] found that H.pylori showed increased seroprevalence 
(88%) among individuals who consumed water from surface sources when 
compared with individuals who consumed water from deep wells (73%). 
 
Hygiene : 
Several studies showed that poor hygienic practices were associated 
with increased risk of H.pylori infection mainly during childhood [45,48]. 
 
Overcrowding: 
 Several studies found the significance of association seen between 
H.pylori infection and crowded environment which increases the rate of 
transmission among family members [45,48]. 
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Family History: 
 Brenner et al in his recent study [53] stated that there was increased 
risk of H.pylori infection among adults who had a parental history of 
carcinoma stomach than that of subjects without such history. 
 
                          ROUTES OF TRANSMISSION [54] 
 The main route of transmission of H.pylori is by contact between 
person-to-person. 
 
 There are 3 possible ways of transmission of H.pylori from one 
individual’s stomach to other individual [21]. 
 
(1) Iatrogenic 
 This is the most common route of transmission that occurs by the 
usage of endoscopies or tubes which come in contact with one individual’s 
gastric mucosa that can be used for other patient . 
 
 Increased rate of infection was also seen in certain occupations like 
gastroenterologists and endoscopists [21,57]. 
 
(2) Fecal-oral 
 Among 407 children in the age group of 2 months to 12 years, a study 
was conducted at Peru which concluded that the prevalence rate of H.pylori 
18 
 
infection was higher in children who consumed municipal water when 
compared with children who consumed water in private wells [56]. 
 
Several studies found that in young infected children H.pylori was 
isolated from the feces [21,57]. 
 
Water contaminated with feces may also be a route of transmission.  
 
(3) Oral-Oral 
 The possibility of spread of H.pylori by oral-oral route has been 
observed in sharing of same spoon by both the child and mother, intake of 
premasticated foods which is common among few ethnic groups [21,55] and 
rarely by aspiration of vomit. 
 
PATHOGENESIS 
 
The virulence of H.pylori depends on the following factors. 
• Flagellae – This helps in the mobility of organisms in viscous mucus. 
• Adhesins – This helps the bacteria to adhere to surface foveolar cells. 
• Urease – This causes metabolism of endogenous urea and liberates 
ammonia and causes rise in gastric pH. 
• Toxins – Play a main role in the development of ulcer and gastric 
cancer.  The toxin mainly involved is Cytotoxin – associated gene 
(CagA). 
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Outer membrane protein : 
 Helicobacter pylori consists of five families of major outer membrane 
protein.  The major family is formed by adhesins.  The rest is constituted by 
iron transporters, porins, flagellum – associated proteins and proteins of 
unknown function.  Lipopolysaccharides (LPS) and phospholipids are found 
on the outer membrane.  H pylori consists of 4-6 sheathed flagellae which 
helps in their motility [58]. 
 
Adhesins : 
 The pathogenesis of H.pylori infection depends upon the type of 
strain, host and environmental factors.  The presence of flagellae helps the 
organism to reach the gastric mucoid lining [59].  By means of chemotaxis 
H.pylori moves away from the acidic pH of the lumen and reach the surface 
of epithelial cells which have neutral pH [60]. The adherence to the 
epithelial cell is favoured by  adhesins produced by the bacteria. 
 
Urease : 
 Urease is produced in large amounts by Helicobacter pylori.  The 
endogenous urea is metabolized by this urease which results in the 
formation of ammonia and carbondioxide.  The ammonia reacts with water 
and forms ammonium and the remaining hydroxyl ions combines with 
carbondioxide and leads to the production of bicarbonate.  This bicarbonate 
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causes neutralization of gastric acid.  Urease enzyme has a major role in the 
survival of Helicobacter pylori in the acidic environment of stomach. 
 
Helicobacter pylori also produces vacuolating cytotoxin A (VacA), 
proteases and phospholipases which cause epithelial cell damage [61]. 
 
Following attachment of Helicobacter pylori to the gastric epithelium, 
the cag expressed type IV secretion system “injects” their cell wall 
peptidoglycan which is an inducing agent of inflammation into the gastric 
epithelial cells.  The cytoplasmic pattern recognition receptor Nod 1 senses 
these peptidoglycans and promotes inflammation [62] by the expression of 
cytokines. 
 
Gastric epithelium expresses Interleukin-8 a chemokine which causes 
potent activation of neutrophils and mediates inflammation [63]. 
 
SYDNEY GRADING SYSTEM OF GASTRITIS 
 
Gastritis can be classified into acute and chronic. 
 
Chronic gastritis is further divided into non-atrophic and atrophic 
gastritis.  Non-atrophic chronic gastritis is usually seen in H.pylori infection 
and atrophic gastritis is of autoimmune etiology.  Helicobacter pylori also 
has a role in the etiology of multifocal atrophic gastritis. 
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Other forms of gastritis include 
- Lymphocytic gastritis 
- Radiation gastritis 
- Reactive gastritis (chemical) 
- Eosinophilic gastritis 
- Non-Infectious granulomatous gastritis 
- Infectious gastritis 
 
In 1990, at the 9th World congress of Gastroenterology in Sydney, 
Australia a group of experts devised the Sydney system of grading and 
classification of gastritis. 
 
In 1994 in Houston, Texas the Sydney system was updated by the 
experts [65]. Several histopathological variables were graded on a scale of 
3. They are graded as mild, moderate and severe 
 
Graded variables include 
- Neutrophilic infiltration 
- Mononuclear infiltration 
- Helicobacter pylori density 
- Atrophy 
- Intestinal metaplasia and dysplasia 
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Biopsy Sites :[65,66]  
 According to Bayerdorffer E-oertil H.Lehn.N. et al, multiple biopsies 
are usually recommended for accurate detection of H.pylori. Biopsy sites 
include two corpus and two antral specimens.  
 
 Antral biopsies show a very low density of organisms in patients  who 
are under treatment with proton pump inhibitors.  In such cases, corpus 
biopsies are needed for demonstrating the presence of H.pylori infection . 
 
 Incisura angularis reveals a greater degree of intestinal metaplasia  , 
atrophy and this is the site which is also more prone for malignant dysplasia.  
Hence additional biopsies are also taken from this site. 
 
GRADED VARIABLES : 
H.Pylori density : 
 For effective clinical management, it is essential to diagnose the 
existence of H.pylori in gastric biopsies.  The variations in the density of 
H.pylori may have epidemiological importance and have an association with 
many diseases . 
 
Polymorphonuclear neutrophil activity : 
 It measures the rate of acute inflammation.  Tissue damage is usually 
caused by proteases and reactive oxygen species which are derived from 
neutrophils. 
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 In H.pylori positive individuals neutrophils are seen with in the 
epithelium, in lamina propria and also in the foveolar lumen forming “pit 
abscesses”. 
 
The severity of H.pylori infection  and the level of mucosal damage 
usually correlate with the density of neutrophils in the epithelium.  
Neutrophil activity is a very useful indicator of H.pylori infection.The 
presence of neutrophils in post-treatment biopsies is highly suspicious of 
H.pylori infection.  Here comes the use of immunostains or special stains  
for detecting H.pylori. 
 
Chronic inflammation : 
 Scattered chronic inflammatory cells are normally seen in the gastric 
mucosa.  In H.pylori infection there is increase in the density of chronic 
inflammatory cells which includes B-lymphocytes, CD4+ and CD8+ T 
lymphocytes, monocytes, eosinophils, plasma cells and mast cells. 
 
It may take several years for the chronic inflammatory cells to 
disappear or become normal in gastric mucosa even after complete 
eradication of H.pylori . 
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Glandular atrophy : 
 Atrophy refers to the loss of gastric mucosal glands which leads to 
mucosal thinning and ultimately causes severe damage to the mucosa.  
Atrophy results from severe inflammation or follow ulceration or erosion of 
the mucosa.  Another microscopic evidence of atrophy is the presence of 
intestinal metaplasia which replaces the antral epithelium. 
 
 Loss of secretion of acid  leads to oxyntic mucosal atrophy followed 
by intestinal metaplasia and carries a higher level of risk for the 
development of gastric cancer . 
 
 Presence of severe atrophy in antral mucosa and its association with 
intestinal metaplasia is also more prone for gastric cancer . 
 
Intestinal metaplasia : 
 This is more common in all forms of chronic gastritis.  Intestinal 
metaplasia is classified into 3 types based on its glycoprotein content and 
morphology by using mucin histochemistry .  Intestinal metaplasia carries 
increased risk for developing malignancy. 
 
In a study conducted at Slovenia it was found that patients with type 
III intestinal metaplasia have 2.7 to 5.8 times more risk for gastric cancer 
development than with subjects having type I & II intestinal metaplasia . 
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NON-GRADED VARIABLES: 
Surface epithelial damage, erosion and mucin depletion  
 These features are seen in cases of active H.pylori infection and 
associated with the risk of peptic ulcer which is related to production of 
cytotoxin.  This epithelial damage occurs as a result of inflammation caused 
by neutrophilic infiltration which measures the “activity”. 
 
Lymphoid follicles : 
 The characteristic feature seen in H.pylori gastritis is the presence of 
lymphoid follicles with germinal centre formation . 
 
 If the follicles are irregular in shape and larger in size and show the 
presence of extensive mucosal infiltration by dense lymphocytic population 
one should consider the possibility of Mucosa associated lymphoid tissue 
(MALT) lymphoma . 
 
Foveolar hyperplasia : 
 It is identified by the presence of tortuosity and increased length of 
the foveolae, depletion of mucin in cytoplasm and a relative increase in the 
size of nuclei.  This occurs due to the effect of stimulation by cytokines or 
inflammatory mediators like transforming growth factor alpha (TFG α)  or 
as a compensatory mechanism to excessive cell exfoliation. 
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Pseudopyloric metaplasia : 
 For accurate classification and localisation of atrophic gastritis it is 
necessary to distinguish between true antral glands and pseudopyloric 
glands in a biopsy specimen. 
 
Pancreatic (acinar) metaplasia : 
 It is usually seen in association with chronic gastritis, Intestinal 
metaplasia and seen in 1 to 2% of gastric specimens . 
 
Endocrine cell hyperplasia : 
 Several functional changes occur in cases of chronic gastritis which 
leads to endocrine cell hyperplasia.  It is the most prominent feature seen in 
autoimmune atrophic gastritis.   
           In autoimmune gastritis patients, smaller percentage of individuals 
have the chance of progression to carcinoid tumor. 
 
27 
 
 
                                     Sydney grading system of gastritis 
Table-1 
Features Grade 
Chronic 
Inflammation Mild Moderate Severe 
Atrophy Mild Moderate Severe 
Activity < 1/3 of Pits mild 1/3 to 2/3 
moderate > 2/3 Severe 
Intestinal 
Metaplasia Mild Moderate Severe 
H.Pylori 
colonisation 
< 1/3 of surface 
mild 
1/3 to 2/3 
moderate > 2/3 Severe 
 
 
Phenotypes of gastritis :[66,67] 
 It can be categorized as  
  Atrophic 
  Non-atrophic 
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Non-atrophic gastritis : 
Antral predominant non-atrophic gastritis 
This is the most common type of presentation of H.pylori gastritis in 
western world. 
 
Characterised by 
1) Absence of atrophy. 
2) Antral inflammation ranges from moderate to severe. 
3) Corpus may be mildly inflammed or normal. 
 
Mostly these patients are asymptomatic and have estimated lifetime 
risk of about 20% for developing duodenal ulcer and minimal increased risk 
for the development of gastric adenocarcinoma [68] when compared with 
normal population.  
 
Non-atrophic pangastritis : 
 In case of H.pylori infection, there will be presence of marked 
inflammation involving the entire stomach with minimal or no difference 
between corpus and antrum. 
 
 H.pylori is highly endemic in areas with poor sanitation and the 
affected individuals develop pangastritis which serves as a background for 
the development of atrophy [69]. 
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Atrophic Chronic gastritis : 
 Gastric mucosal atrophy refers to the loss of appropriate glands [70].  
Due to severe inflammation the glands are damaged and have undergone 
metaplastic change or replaced by connective tissue.  Intestinal metaplasia is 
the most common transformation occurs in the glands but sometimes in 
oxyntic mucosa, pseudopyloric metaplasia occurs which consists of mucin-
secreting antral glands. 
 
Antrum restricted atrophic gastritis : 
 In this type  the atrophic changes are mainly seen in the antrum. 
These atrophic and metaplastic changes occur as a result of consequence of 
past or present infection with H.pylori. 
 
 Biopsies usually reveal patchy metaplastic atrophy confined mainly to 
distal portion of mucin secreting mucosa and associated with moderate to 
severe inflammation.  Corpus is usually normal or shows mild inflammation 
and absence of atrophic changes. 
 
Corpus restricted atrophic gastritis : 
 In this type, atrophic – metaplastic changes are seen in the oxyntic 
mucosa without any associated atrophic changes in the antrum or distal 
stomach.  It is mainly of autoimmune etiology and carries increased risk for 
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gastric cancer . Rarely it is associated with atrophy of antral mucosa arising 
from concurrent infection with H.pylori. 
 
Multifocal atrophic gastritis : 
 It was previously called as Environmental chronic atrophic gastritis. 
 
 It is more common in individuals living in poor sanitary conditions 
such as Latin America, Southern Asia, Eastern and southern Europe  
[71]. 
 
 Both the antral and corpus mucosal biopsies show the presence of 
atrophic and metaplastic changes.Oxyntic mucosa reveals severe 
inflammation.  Atrophic gastritis is considered as a major risk factor for the 
development of intestinal type adenocarcinoma, gastric non-invasive 
neoplasia and gastric ulcer . 
 
Atrophic pangastritis : 
 It represents the advanced stage of multifocal atrophic gastritis and 
carries increased risk for the development of both noninvasive and invasive 
gastric neoplasia . 
 
 Khan MQ et al (1999) conducted a study for  identifying H.pylori  in 
cases of gastroduodenitis  and nonulcer dyspepsia and found that 74% of 
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individuals were positive for H.pylori in cases of non-ulcer dyspepsia and 
68% in cases of gastroduodenitis [72]. 
 
 In a study conducted by kalebi A et al (2007) it was found that the 
major cause of gastritis was H.pylori infection [73] and was common in the 
antrum with evidence of chronic inflammation in 98% cases and 
neutrophilic infiltration in 91% of cases. 
 
 Yamaoka et al (1997) graded the density of H.pylori in gastritis cases 
based on the Sydney system [74].  It was graded as absent, scanty, moderate 
and heavy colonisation. 
 
 In his study Warren JR (2000) found that H.pylori plays a major role 
in the etiology of non-erosive nonspecific gastritis [75]. 
 
KOJK et al in his study [76] found the association between cigarette 
smoking and intake of alcohol with peptic ulcer. Intake of alcohol is related 
with increased risk of chronic gastritis and these are mainly linked to the 
inflammatory changes caused by concurrent infection with Helicobacter 
pylori.  Chronic alcoholism also affects normal gastric mucosal barrier and 
associated with gastric metaplasia. 
 
Adisa et al [77] conducted a retrospective study of 603 antral 
biopsies.  These antral biopsies were stained by different methods which 
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include Hematoxylin and Eosin method, Grocott’s modification of 
Hexamine silver method and Giemsa method.  572 (94.9%) patients showed 
the presence of gastritis with highest age incidence seen among  
31 – 40 years (24.8%)  H.pylori infection was seen in 345 (57.2%) cases and 
the peak incidence was seen in the age group of 41 – 50 years (26%).  Early 
detection and eradication of H.pylori were effective in the prevention of 
gastric cancer.  
 
Chow JY et al [78] assessed the effect of cigarette smoking in relation 
to healing of gastric ulcer.  Cigarette smoking causes increased production 
of nitric oxide, leukoterines and enhances the activity of Xanthene oxidase.  
It also leads to decreased proliferation of epithelial cells, lowers the blood 
flow, blood vessels formation and the production of prostaglandins.  These 
are the factors which are essential for formation and healing of ulcer.  This 
proves the harmful effects of cigarette smoking on gastric mucosa. 
 
Rajeshkumar et al [79] conducted a study on 265 patients for the 
detection of H.pylori by using histopathological examination and urease 
test.  Among 265 cases, 92 patients (34.71%) showed positivity for 
H.pylori.  Out of this 92 patients there were 59 males and 33 females.  In 
H.pylori infected individuals, the minimum age of positivity was 18 years 
and the maximum age was 74 years.  The highest incidence was seen in the 
age group of 36 – 45 years. 
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In endoscopy and histopathological examination the features seen 
were chronic superficial gastritis in 87 patients which was the most common 
presentation.  8 patients showed features of esophagitis and 11 showed 
duodenitis.  4 Patients showed the presence of duodenal ulcer and chronic 
gastric ulcer in 2 patients.  Multiple changes were seen in the same patients. 
 
The infection rate was higher (32/92) among individuals living under 
poor sanitation, high density or overcrowding, low socioeconomic status.  
Anti-H.pylori treatment was started in all the positive individuals. 
 
Riba et al [80] and colleagues in their study compared the 
effectiveness of immunohistochemical  technique by using polyclonal and 
monoclonal antibody for detecting Helicobacter pylori.  300 H.pylori 
positive cases of gastritis were studied by using these antibodies.  
Monoclonal antibody identified 96.2% of cases and 98.5% cases were 
detected by polyclonal antibody method.  They also compared these 2 
methods for better morphology of organism and background staining.  
Better preservation of morphology of organism and low level of background 
staining were seen in new H.pylori monoclonal antibody when compared 
with the polyclonal antibody.  
 
In a study by Kacar et al [81] he included 60  H.Pylori positive and 10 
H.pylori negative cases.  These cases were tested  by using urea breath tests, 
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histopathological examination, urease test for H.Pylori.  Further these tissue 
sections were submitted  for different staining methods like Hematoxylin 
and Eosin (H&E), modified Giemsa,  Toluidine blue and 
immunohistochemistry.  Using double blinding method these samples were 
assessed by pathologists.  Using Kappa statistics the interobserver variations 
were analysed.  It was evident from this study, demonstration of  H.pylori 
on tissue sections was possible regardless of the stain performed.  Modified 
Giemsa stain and Immunohistochemistry are considered as the best 
methods.  The reliability, cost and the applicability of Giemsa stain makes it 
as the best choice in the detection of H.pylori on gastric biopsies. 
 
Other types of gastritis :[82] 
Acute gastritis : 
 The common etiological factors include ingestion of salicylates, 
alcohol, bile reflux or intake of anti-inflammatory drugs. Also known as 
chemical or reactive gastropathy .Microscopy reveals no significant 
inflammation but foveolar and glandular lumina show some degree of 
infiltration by neutrophils.[82] 
 
Hemorrhagic gastritis : 
 It is seen in the setting of chronic gastritis and manifests as a severe 
life threatening condition.  The precipitating factors include alcohol, stress, 
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anti-inflammatory drugs  and cytomegalovirus infection . Microscopy shows 
the presence of chronic atrophic gastritis.[82] 
 
Lymphocytic gastritis : 
 It is characterized by the presence of increased intraepithelial 
lymphocytes seen in the surface and foveolar epithelium.  It is commonly 
associated with H.pylori infection or celiac disease and resembles 
lymphocytic colitis . 
 
Collagenous gastritis : 
 Presence of thick band of collagen in the subepithelium is the 
characteristic feature and eosinophils constitute the major inflammatory 
infiltrate in the gastric mucosa. 
 
Granulomatous gastritis : 
Commonly seen in cases of Tuberculosis , Crohn’s disease , mycosis 
and sarcoidosis [82]. 
 
Allergic gastroenteritis : 
 Associated with degenerative and regenerative changes in the 
foveolar and surface epithelium .Microscopy shows the presence of 
eosinophils in the lamina propria.[82] 
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GASTRIC CARCINOMA 
 
 Gastric cancer was the second most common cancer in the world. 
60% of cases were usually seen in developing countries [84]. 
 
Location :[83] 
- The most common location is the antropyloric region. 
- Also occurs in the corpus or body of stomach along greater or 
lesser curvature. 
 
H.pylori infection :[83] 
 It plays a main etiological role in the development of gastric 
adenocarcinoma.  Several studies emphazise that there is increased risk in 
patients who  had anti-H.pylori antibodies in stored serum samples 10 or 
more years before the diagnosis of cancer [85,86].  H.pylori causes several 
phenotypic changes which leads to the development of adenocarcinoma.  
These changes includes mucosal atrophy , intestinal metaplasia and 
dysplasia .In cases of gastritis and atrophy, there is elevation of gastric pH 
which alters the bacterial flora results in colonisation of stomach by 
anaerobic bacteria which produces active reductases. These active 
reductases convert food nitrate into nitrite which reacts with amines, amides 
and urea which leads to the production of carcinogenic N-Nitroso 
compounds .  H.pylori genome is heterogenous and infections with strains 
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having cag group of genes [87] exhibit strong association with the 
development of gastric carcinoma .  The mechanism commonly involved is 
epithelial production of interleukin  8 via nuclear factor kappa B pathway. 
 
H-pylori also produces vac A which is a vacuolating  cytotoxin which 
plays a role in gastric carcinogenesis  and also causes epithelial cell damage.  
Inoculation of cag and vac A positive strain in Mongolian gerbils [88] 
produces intestinal metaplasia and gastric carcinoma which confirms the 
role of H.pylori in gastric carcinogenesis. 
 
Excessive cell proliferation is usually seen in H.pylori infected 
individuals.  Eradication of H.pylori results in decreased cell proliferation  
which supports the mitogenic influence of H.pylori on gastric epithelium.  
Due to potent urease activity exhibited by H.pylori there is release of 
ammonia which increases cell replication. 
 
Ascorbic acid is an antioxidant which has anticarcinogenic role.  It 
acts by preventing oxidative DNA damage.  Intragastric  concentrations of 
ascorbic acid are usually lower in H.pylori infected cases than in non-
infected individuals and its level increases to that of non-infected persons 
after H.pylori treatment .  
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Dietary factors[83] 
 Excessive salt intake increases the risk of gastric cancer .  Adequate 
intake of vegetables and fresh fruits are associated with low risk of gastric 
cancer development .Pickled vegetables, smoked meat or fish are associated 
with high risk of gastric cancer. 
 
Bile reflux : 
 The risk for gastric carcinoma is more after 5 – 10 years in case of 
individuals who underwent Bilroth II operation which causes increase in 
bile reflux. 
 
Association between Gastric Carcinoma and H.pylori infection : 
 Yokota et al [89] in his study established the presence of infection 
with H.pylori in Mongolian gerbils.  These animals develop intestinal 
metaplasia and severe gastritis [89,90]. 
 
Watanabe et al [88] in his study found that 30% of Mongolian gerbils 
infected with H.pylori developed adenocarcinoma.  Mostly these tumors 
were well differentiated adenocarcinoma – Intestinal type. 
 
Sugiyama et al [91] in his study he assessed the carcinogenic effect of 
H.pylori.  The carcinogenic effect of known carcinogens like N-methyl-N-
nitrosourea when present in low levels, is enhanced by H.pylori. For 
H.pylori infected animals, low dose N-methyl-N-Nitrosourea was added in 
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drinking water for a period of 6 weeks.  Adenocarcinoma was developed in 
33% of infected animals.  
 
Uemura  et al [92] in his study documented that the risk of developing 
recurrent adenocarcinoma is lowered in individuals in whom H.pylori 
eradication had been done after mucosal resection of carcinoma done during 
a screening program. 
 
Hansson et al [93] and parsonnet et al found that duodenal ulcer 
affords protection from gastric cancer. 
 
Crabtree et al [94] in his study showed the presence of  IgG antibody 
specific to H.pylori in 70% of persons with gastric cancer. 
 
In a prospective study by Uemura and okamoto [95] among 132 cases 
of early gastric cancer eradication of H.pylori was done in 50% of patients 
at the time of resection of early gastric cancer.  After 2 years it was found 
that the recurrence of adenocarcinoma was significantly lower than control 
group in whom H.pylori eradication was not done. 
 
Oda et al [96] in his study showed the role of p53 gene mutation as a 
causative or associative factor in the etiology of gastric cancer associated 
with H.pylori infection. 
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Murakami et al [97] found the presence of p53 gene mutations in 53% 
of human mucosa infected with H.pylori and in 100% of infected monkey 
mucosa. 
 
Hoshi T et al (1999) in his study, found that in H.pylori associated 
chronic gastritis there was increased cell proliferation in response to cell 
injury.  Incomplete intestinal metaplasia and increased proliferative activity 
result in instability of DNA and leads to the development of gastric 
adenocarcinoma – intestinal type in the mucosa of individuals infected with 
H.pylori.  So, H.pylori eradication not only has a substantial role in the 
treatment of gastric ulcers and gastritis but also prevents the development of 
intestinal type gastric adenocarcinoma [98]. 
 
In a study by Kusters JG et al (2006) in developed countries, 60 to 
80% of gastric carcinomas occur as a result of long term consequence of 
infection with H.pylori.  In case of H.pylori infection, there is excessive 
production of reactive oxygen species due to ongoing inflammation which 
causes DNA damage and initiates the cascade of development of gastric 
cancer.  It was estimated that there was tenfold increased risk of gastric 
cancer development in H.pylori infected Individuals and H.pylori was 
declared as class I human carcinogen by the WHO [99]. 
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Histopathology of Gastric adenocarcinoma :[83] 
WHO Classification : 
Tubular adenocarcinoma : 
   -Tumor cells are arranged in the pattern of branching tubules.  The 
cells are cuboidal, columnar or flattened due to the presence of intraluminal 
mucin. 
- Cells exhibit varying degree of cytological atypia . 
 
- When prominent lymphoid stroma are seen in these tumors they 
are termed as carcinoma with lymphoid stroma or medullary 
carcinoma.   Solid carcinoma refers to the poorly differentiated 
variant. 
 
Papillary adenocarcinoma : 
 This type shows the presence of papillary processes which are finger 
like elongated structures with fibrovascular core.  These papillae are lined 
by cuboidal or cylindrical cells.  The tumor also shows the presence of acute 
and chronic inflammatory cells.  Tumor cells show varying degree of atypia. 
 
Mucinous adenocarcinoma : 
- Extracellular mucin pools should occupy more than 50% of the 
tumor. 
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- Tumor cells may be arranged in glandular pattern where the cells 
lining the glands are mucus secreting columnar.  Interstitium also 
shows the presence of mucin. 
- Tumor cells also seen in dyscohesive clusters floating in pools of 
mucin. 
 
Signet ring cell adenocarcinoma : 
 Tumor cells containing intracytoplasmic mucin should constitute 
more than 50% of tumor which may be arranged in small clusters or singly 
scattered.  The morphology of tumor cells is of 5 types.  
 
1) Nuclei seen pushing against the cell membrane giving the 
appearance of signet ring and the cytoplasm is optically clear, 
globoid.  The mucin is of acidic nature which stains with Alcian 
blue at pH 2.5. 
 
2) Cells resembling histiocytes with central nuclei are seen in cases 
of diffuse carcinoma. 
 
 
3) The cells are small with deep eosinophilic cytoplasm, the 
cytoplasm shows the presence of granules with neutral mucin. 
 
4) Cells which are small with scant or no mucin. 
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5) Anaplastic cells with scant or absence of mucin. 
 
The tumor is constituted by varying proportions of these cells.  
 
Lauren Classification :[83] 
 The Lauren Classification has evaluated the association of gastric 
cancer with incidence trends, environmental factors and its precursor 
lesions.  It also evaluated the history of carcinoma stomach. 
 
This consists of  
- Intestinal type 
- Diffuse type. 
 
 Tumors which contain both the components in equal proportions are 
termed as mixed carcinomas. 
 
Indeterminate category includes the tumor that do not fit into either of 
these two categories. 
 
Intestinal Carcinoma : 
 Intestinal metaplasia serves as a background for the development of 
this type of carcinoma.  It consists of recognisable glands that show 
varying degree of differentiation ranges from well to moderate. 
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Diffuse Carcinoma : 
 This shows the presence of poorly cohesive tumor cells and absence 
of glandular formation.  Cells are small and round scattered singly or in 
dyscohesive clusters.  Mitotic rate is lower than in intestinal tumors.  There 
is evidence of increased desmoplasia and the inflammatory changes are 
minimal. 
 
Grading :[83] 
Well differentiated : 
It is composed of well formed glands which have the appearance of 
metaplastic intestinal epithelium. 
 
Moderately differentiated : 
It forms the intermediate category between well and poorly 
differentiated forms.  
 
Poorly differentiated : 
It is composed of tumor cells that are scattered singly or seen in small 
groups with mucin secretions.  Glandular structures are rarely seen. 
 
Well and moderately differentiated tumors are considered as low 
grade and poorly differentiated tumors as high grade. 
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Other Clinical outcomes associated with H.pylori[1] 
Duodenal and gastric ulcer : 
 H.pylori is found to be associated with 90% of duodenal ulcers [101].  
In H.pylori negative individuals other causative agents  like nonsteroidal  
anti-inflammatory drug usage and Zollinger-Ellison syndrome are 
considered . 
 
In tropical countries, most gastric ulcers are associated with infection 
with H.pylori .  In cases of duodenal ulcer, the cytotoxin cagA produced by 
H.pylori causes more severe inflammation . 
 
Some studies assessed the major causative role of H.pylori in peptic 
ulcer [102] and all patients of peptic ulcer should be screened and the 
affected individuals are treated with antimicrobial agents . 
 
Recurrence rate is more common of about 90%, if the organisms 
persist and complete cure of the ulcer is possible with effective treatment 
with antibiotics [103,104,105,106].  
 
Lymphoma : 
Wotherspoon et al in his study found that H.pylori was positive in 
92% of 110 mucosa associated lymphoid tissue (MALT) lymphoma cases 
when compared with 50% of control groups. 
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Further studies suggested that the pathogenesis of these tumors was 
greatly influenced by the continuing antigenic stimulus of H.pylori and 
effective treatment of this infection causes tumor regression [107]. 
 
The German MALT – lymphoma study group also concluded that 
complete eradication of H.pylori has caused apparent cure in 50% of cases 
of MALT lymphoma. 
 
Esophageal diseases: 
Many studies found that there was inverse association seen between 
the H.pylori infection with CagA+ strains and Barretts esophagus and 
adenocarcinoma of esophagus [108,109,110]. 
 
The risk of development of gastroesophageal reflux disease was 
doubled in cases of patients with duodenal ulcer after H.pylori eradication . 
 
The colonisation of H.pylori is usually lower in patients with 
gastroesophageal reflux disease when compared with the control group 
[111]. 
 
H.pylori colonisation for a long period of time in the stomach 
decreases the acidity of the stomach which may plays a role in the 
protection of esophagus. 
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Asthma and related disorders : 
 Reibman and colleagues [112] found an inverse relationship seen 
between infection with H.pylori and the development of eczema, allergic 
rhinitis, skin allergies and asthma. 
 
Idiopathic thrombocytopenic purpura : 
 Numerous reports from East Asia during the past 10 years showed 
that there was significant epidemiological association seen between the 
diagnosis of idiopathic thrombocytopenic purpura (ITP) [113,114] and 
H.pylori infection.  So, patients of ITP are now evaluated for  H.pylori 
infection and if it is found to be positive, eradication of H.pylori is now 
considered as one of the treatment modality. 
 
Diagnosis of H.pylori :[1,2] 
The diagnostic tests are categorized into 2 types. 
1. Endoscopic tests 
2. Non endoscopic tests 
Endoscopic tests: 
These include four diagnostic methods based on biopsy. 
- Rapid urease testing 
- Histology 
- PCR 
- Culture 
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Rapid urease testing: 
 This test depends upon the urease activity of H.pylori organisms. In 
this method, gastric biopsies are placed into a medium of agar gel or on a 
reaction strip which contains urea, pH indicator and a buffer. 
 
In the presence of organism, urea is metabolized by H.pylori’s urease 
activity which results in the formation of bicarbonate and ammonia. This 
leads to increase in pH which causes colour change in pH sensitive indicator 
and confirms the existence of active infection due to H.pylori. 
 
The sensitivity of the test can be reduced upto 25% by the use of 
medications such as proton pump inhibitors, antibiotics and bismuth 
containing compounds which decrease the urease activity and density of 
H.pylori. 
 
Several studies found that the negative predictive value and 
sensitivity of rapid urease test were decreased due to the presence of active 
bleeding from ulcer at the time of diagnosis [116,117]. 
 
Histology: 
 Several studies found that histopathological examination remains the 
gold standard method for H.pylori identification [118]. 
 
49 
 
 The major advantage of histology when compared to other methods is 
that it is possible to identify several pathological changes which are 
diagnostic of H.pylori infection. These changes include atrophy, 
inflammation, intestinal metaplasia and malignancy . 
 
 Certain medications such as proton pump inhibitors, bismuth and  
antibiotics affect the sensitivity of histology . 
 
 As the H.pylori density in stomach is usually low in cases of 
medications, multiple biopsies are usually taken for exact diagnosis. 
Multiple biopsies are taken from sites including angularis, greater curvature 
of antrum and greater curvature of corpus [118]. 
 
Culture: 
 This method is highly specific for H.pylori detection but the 
sensitivity is low when compared to histology or rapid urease kit . 
 
 The major advantage of culture is that in addition to identify the 
organisms it also finds the sensitivity of organisms to antimicrobials . 
 
Polymerase chain reaction: 
 This method is highly sensitive and more specific than other 
diagnostic methods.  In a study on chronic gastritis Polymerase Chain 
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Reaction (PCR) detected H.pylori infection in 20% of cases whose gastric 
biopsies revealed no organisms by histology . 
 
 Polymerase Chain Reaction also plays a role for detecting mutations 
seen with antimicrobial resistance [119]. It provides a best tool for typing of 
organisms and testing of virulence of organisms [120]. 
 
Non-Endoscopic diagnostic methods : 
These include 
• Antibody tests 
• Urea breath tests 
• Fecal antigen test 
 
Antibody tests : 
 This test detects the presence of  IgG antibodies specific to H.pylori 
in whole blood, serum or urine.  These antibodies are usually seen 
approximately after 21 days of infection and persist for longtime even after 
eradication [121].  These antibodies can be assessed by both qualitative and 
quantitative methods. Quantitative methods include Enzyme – linked 
immunosorbent assay (ELISA) and latex agglutination tests.  Qualitative 
assessment done by using office based kits. 
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 Antibody tests have a limited role in eradication therapy as these 
antibodies remain positive for longtime even after successful eradication of 
infection [121]. 
 
Urea Breath tests : 
 This test identifies the organism by means of H.pylori urease activity.  
After ingestion of urea labeled either with radioactive isotope 14C or non-
radioactive isotope 13C in the presence of organisms, there will be 
production of labeled carbondioxide which is measured in expired breath 
[2,122]. 
 
In pregnant women and children 13C test is mostly preferred [122].  
The sensitivity of the test is affected by certain medications like antibiotics, 
proton pump inhibitors and bismuth containing compounds.  It is generally 
recommended that proton pump inhibitors should be withheld for 7-14 days, 
antibiotics and bismuth to be withheld for atleast 28 days prior to the urea 
breath tests [115]. 
 
Fecal Antigen Test : 
This test identifies the presence of H.pylori antigen in stool by means 
of enzyme immunoassay using polyclonal anti-H.pylori antibody.  Several 
studies found that fecal antigen test may be useful in confirming eradication 
during the early period itself where it is seen after 14 days of treatment 
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[123,124].  Usage of antibiotics, bismuth compounds and proton pump 
inhibitors affect the sensitivity of the test . 
 
Treatment 
Indications :[1] 
 -In case of peptic ulcer patients who are positive for H.pylori, a 
significant reduction in the recurrence rate of ulcer was seen after 
eradication of H.pylori  . 
 
 - In duodenal ulcer cases antimicrobial therapy is now considered as 
the major form of treatment .  Similar form of therapy is also indicated in 
cases of H.pylori associated gastric ulcers. 
 
-In cases of gastric MALTomas, eradication of H.pylori causes 
regression of tumor .   
 
-H.Pylori eradication therapy is also useful in cases of Idiopathic 
thrombocytopenic purpura . 
 
 
               Some studies [125,126] suggested that the H.pylori infection has a 
protective role against diarrheal diseases and eradication of H.pylori 
increases the rate of morbidity and mortality among children in developing  
countries. 
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Treatment Regimens [1]   
The most common treatment regimens used in H.pylori infections are  
 
Quadruple therapy: 
Proton Pump inhibitors twice daily+ 
Tetracycline 500 mg. thrice daily+ 
Metronidazole 500 mg. 3 times a day+ 
                                                    Bismuth                   for a period of 10 days. 
 
Proton pump inhibitors (PPI) triple therapy: 
 
Proton pump inhibitors twice daily+ 
Clarithromycin 500 mg. two times daily+ 
Amoxicillin 1 g. two times daily 
for a period of 7 to 10 days 
 
Levofloxacin triple therapy: 
Proton pump inhibitors two times daily+ 
Levofloxacin 500 mg. two times daily+ 
Amoxicillin 1 g. two times daily 
                                                                for a period of 10 days 
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Sequential therapy: 
Proton pump inhibitors twice daily+ 
Amoxicillin 1 g. twice daily 
for  a period of 5 days which is followed by  
Proton pump inhibitors twice daily+ 
Tinidazole 500 mg. twice daily+ 
Clarithromycin 500 mg. twice daily 
for a period of 5 days 
Rifabutin triple therapy: 
 
Proton pump inhibitors twice daily+ 
Rifabutin 150 – 300 mg/day+ 
Amoxicillin 1 g. twice daily 
for a period of 10 days 
 
 These agents are potent inhibitors of urease enzyme and also have a 
direct inhibitory effect on H.pylori . 
            Gastric hormones such as ghrelin and leptin are affected by 
eradication of H.pylori which have an effect on satiety and appetite . 
 
Predictors of H.pylori treatment outcome:[2] 
 The major factors involved in treatment failure are antibiotic 
resistance and poor patient’s compliance. 
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 Dietary factors, consumption of alcohol and smoking also affect the 
successful eradication of H.pylori . 
 
H.pylori treatment is usually associated with minimal side effects  
- Diarrhea and headache are the common side effects seen with 
Proton pump inhibitors. 
- Clarithromycin therapy causes alteration in taste sensation, 
diarrhea and gastro intestinal symptoms. 
- Gastrointestinal upset, nausea, darkened stool, darkening of the 
tongue are the side effects associated with bismuth therapy. 
 
In a study conducted at United States during the period of 1993 to 
1999, H.pylori showed varying rates of antibiotic resistance of about 10% 
for clarithromycin, 37% for metronidazole, 3.9% for both drugs, 1.4% for 
amoxicillin [127]. 
 
 
Consequences of longterm Helicobacter infection :[7] 
 In H.pylori infection the density of bacteria and the severity of 
inflammation are seen more in the antrum.  In case of long standing 
infection, there is involvement of both antrum and corpus which lead to 
development of pangastritis. 
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 Some studies suggested that the intensity of inflammation may 
decrease over a long period of time [128]. 
 
 Several follow up studies [128,129] showed that in long standing 
cases, approximately 10% of patients showed spontaneous regression of 
chronic gastritis.  This may be linked to antibiotic therapy taken for other 
diseases or effective host defence mechanisms. 
 
 Other consequences include peptic ulcer, atrophic gastritis, intestinal 
metaplasia, gastric cancer and lymphoma. 
 
 H.Pylori may rarely cause mucosal fold enlargement in the body of 
stomach. This gives the appearance of hypertrophic gastritis in both 
radiology and endoscopy.  This giant fold gastritis causes several parietal 
cell changes both histologically and ultrastructurally.  These changes 
include formation of intracytoplasmic vacuoles, canalicular dilatation, 
shortening and loss of microvilli.  Eradication of H.pylori infection causes 
reversal of these changes to normal . 
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IMMUNOHISTOCHEMISTRY 
 Immunohistochemistry (IHC) involves the application of both 
Immunology and histology.  It is mainly used to find the expression of 
specific antigen and to locate its exact micro anatomical position in the 
tissue.  The cells exhibit antigenic differences which are distinguished by 
the use of specific antibodies in IHC.  The lineage of cell population and the 
presence of cells that are biologically distinct with in the same lineage are 
specifically identified by these antigenic differences. 
 
The history of IHC was established in 1940 by COONS who 
developed an immunofluorescence technique which identifies in frozen 
sections the presence of specific antigens. 
 
 In 1974, the antigens seen in tissues that are routinely processed are 
demonstrated by Taylor and colleagues. 
 
In 1991, SHI and colleagues established the antigen retrieval 
technique. 
 
In antigen retrieval method before staining for IHC, the paraffin 
sections are heated at high temperature which involves simpler technique. 
 
IHC involves the use of antibody which depends upon the specificity 
and sensitivity of antigen - antibody reaction. 
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Blocking non-specific background staining : 
Background staining occurs because of endogenous enzymes or due 
to non-specific binding.  By means of preincubating sections on optimal 
working dilution with same species serum, the non-specific binding with 
polyclonal primary antibody can be reduced. 
 
Peroxidase is an endogenous enzyme which is present in neoplastic 
and normal tissues.  These enzymes are blocked by peroxidase blocking or 
other methods like Immunogold technique. 
 
There are several methods which are used to block the activity of 
these endogenous enzymes.  Addition of Levamisole in a concentration of 
0.1M to enzyme substrate solution blocks the endogenous alkaline 
phosphatase.  Other method is that at room temperature incubation in 
methanol which contains 0.5% hydrogen peroxide for a period of 10 
minutes completely abolishes the endogenous activity of peroxidase. 
 
Detection Systems : 
 For exact visualisation of the antibodies they are labeled by certain 
substances which include enzymes which form coloured reactions when 
combine with suitable substrate (Light Microscopy), fluorescent substances 
or heavy metals (Electron Microscopy). 
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IHC methods : 
Direct labelling method : 
In this method antibody is applied directly to tissue sections and a 
label is attached by chemical means. 
- It is a simple and fast procedure. 
- The major disadvantage is separate incubation periods are required 
by multiple antigens with corresponding antibodies. 
 
Indirect labelling method : 
In this method, there is production of secondary antibodies against 
primary antibody and this secondary antibody labels the enzyme. 
- It is a simple and more sensitive method. 
- Advantages include higher working dilution of primary antibody, 
secondary antibodies are produced against primary antibodies of 
various species, higher versality and easy preparation.  
 
Avidin biotin techniques : 
 This method involves the use of high affinity binding seen between 
avidin and biotin.  Avidin is chemically conjugated to enzyme and biotin is 
linked to primary antibody chemically.  This involves the binding of avidin 
to the biotinylated antibody and localising the peroxidase moiety at the 
antigenic site. 
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Non-specific background staining produced by the endogenous biotin 
is the major disadvantage of this method. 
 
Avidin Biotin conjugate procedure : 
This method is more sensitive.  In this method first there is addition 
of primary antibody followed by secondary antibody which is biotinylated 
and then by avidin and biotin horse radish peroxidase conjugate complex 
that is preformed. 
 
Biotin streptavidin system : 
 In this system, avidin is replaced by streptavidin and these complexes 
are more stable. 
 
Immunogold silver staining technique: 
 In this method, metallic silver is added in multiple layers which 
enhance the gold particles.  It is used for ultrastructural studies. 
 
Polymeric method: 
 In this technique, via the dextran backbone numerous enzyme 
molecules bind to a secondary antibody.  This method has more advantages. 
 
- Non-specific background staining is minimal. 
- Assay steps are reduced in number. 
- Sensitivity is high. 
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In IHC, the tissue processing involves. 
- Tissue fixation 
- Dehydration 
- Paraffin embedding 
 
Fixation: 
 Better morphological preservation is needed for effective IHC 
interpretation.  The most commonly used fixative is 10% buffered neutral 
formalin due to the following reasons. 
 
1) Cheap 
2) Preservation of morphology is good. 
3) Sterilizes the tissues. 
4) Preservation of Carbohydrate antigen is better. 
 
 The disadvantage is that the antigens are masked by fixation and this 
is rectified by antigen retrieval techniques. 
 
Antigen Retrieval: 
 
 The antigens that are masked during fixation are unmasked by this 
procedure.  There are several methods for antigen retrieval. 
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1) Microwave antigen retrieval 
2) Proteolytic enzyme digestion 
3) Pressure cooker antigen retrieval 
4) Microwave and trypsin antigen retrieval technique 
 
 
 
 
 
Materials and Methods 
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MATERIALS AND METHODS 
 
SOURCES OF DATA: 
 
 This study is a combined retrospective and prospective study .The 
study was carried out in the Institute of Pathology, Madras Medical College, 
Chennai. A total of 150 cases of gastritis and 90 cases of gastric 
adenocarcinoma were received during the period of July 2013 to  June 2014  
and out of this, 40 cases of gastritis and 30 cases of gastric adenocarcinoma 
were randomly selected for this study. 
 
INCLUSION CRITERIA: 
 Endoscopic biopsies and resected specimens of gastric lesions 
 
EXCLUSION CRITERIA: 
   None 
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METHOD OF DATA COLLECTION: 
            
 Relevant clinical details (age, sex) and investigations were collected 
from the medical records of Institute of Pathology, Madras Medical College, 
Chennai. Corresponding histopathological slides prepared from formalin 
fixed paraffin embedded tissue (4 micron thick )of both endoscopic biopsies 
and resected specimens of gastric lesions were subjected to Hematoxylin 
&Eosin staining and studied.  
 Sections from gastritis cases had been categorized using Sydney 
grading system based on activity, chronic inflammation, metaplasia, 
atrophy, Helicobacter pylori colonisation and the results were tabulated. 
Cases of Gastric adenocarcinoma were graded into Well, Moderate and 
Poorly differentiated. 
 Special stains (Giemsa, Toluidine blue) and Immunohistochemical 
study using Helicobacter pylori polyclonal antibody were done in 70 cases 
(including 40 gastritis cases and 30 cases of gastric adenocarcinoma)
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GIEMSA STAINING TECHNIQUE 
Giemsa stock solution: 
 Giemsa stain powder  -  4gm 
 Methanol    -  250ml 
 Glycerol    - 250ml 
The powder is dissolved in glycerol at 60⁰C with regular shaking. 
To this add methanol. 
The mixture is well shaken and then allowed to stand for 7 days.  
Filter it before use. 
Working Giemsa stain: 
 Giemsa stock solution - 4ml 
 Acetate buffered distilled water - 96ml 
METHOD: 
1. Dewax in Xylol, hydrate through graded alcohol water 
2. Rinse in buffered distilled water (pH 6.8) 
3. Stain in working Giemsa stain overnight. 
4. Rinse in distilled water. 
5. Rinse in 0.5 aqueous acetic acid until the section is pink. 
6. Dehydrate, clear in xylene and mount in DPX. 
Result:  
 Microorganism  -  dark blue 
 Background  - pink- pale blue 
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                          TOLUIDINE BLUE METHOD. 
 
Solutions: 
 Toluidine blue in pH6.8 phosphate buffer. 
1% aqueous toluidine blue 1 ml 
Sorenson’s phosphate buffer pH 6.8 - 50 ml 
 
Steps: 
- Deparaffinise and rehydrate through graded alcohol to distilled 
water. 
- Buffered toluidine blue was used for staining for a period of 20 
minutes. 
- Then wash well with distilled water. 
- Dehydrate, clear and mount. 
 
Result: 
 Organisms – Dark blue 
Background – Blue 
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METHODS OF TISSUE PREPARATION FOR IHC 
 10% buffered formalin was used for fixing the specimens, the tissues 
were processed in various grades of alcohol and xylol . Paraffin blocks were 
prepared and sections of 5 microns thickness were cut in semiautomatic 
microtome using disposable blades and stained with Hematoxylin and 
Eosin. Suitable blocks were chosen for IHC. Sections for 
immunohistochemistry were also cut in semiautomatic microtome using 
disposable blades. Slides were subjected to antigen retrieval using the 
microwave technique using TRIS EDTA (pH 9.2) buffer solution and then 
treated by HRP (Horse radish peroxidase) polymer technique. 
 
HRP POLYMER TECHNIQUE 
The coated slides were taken through the following stages 
1. Treatment with peroxidase block – for inhibiting endogenous 
peroxidase in the tissue for 20 minutes. 
2. Wash in TRIS buffer for 5 minutes. 
3. Application of power block – blocks non specific antigen antibody 
reaction –20 minutes. 
4. Blot dry the excess power block. 
5. Application of primary antibody for 60 minutes. 
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6. Wash in TRIS buffer for 5 minutes thrice. 
7. Application of super enhancer for 30 minutes which enhances the 
final reaction product by increasing the sensitivity of antigen antibody 
reaction. 
8. Application of SS label – secondary antibody from goat with the 
tagged horse radish peroxidase enzyme for 30 minutes. 
9. Wash thrice in TRIS buffer. 
10. Application of DAB ( Diamino benzidine ) chromogen for 5 minutes 
– this is cleaved by the enzyme to give the coloured product at the 
antigen sites. 
11. Wash in distilled water for 5 minutes. 
12. The slides are counterstained with hematoxylin. 
13. Air dried and mounted with DPX ( Distrene dibutyl pthalide in xylol). 
 
 
 
 
 
Observation and Results 
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OBSERVATION AND RESULTS 
 
 This study is a combined retrospective and prospective study .The 
study was carried out in the Institute of Pathology, Madras Medical College, 
Chennai during the period of July 2013 to June 2014 .40 cases of gastritis 
and 30 cases of gastric adenocarcinoma were randomly selected for this 
study to detect the presence of Helicobacter pylori using Hematoxylin and 
Eosin, Giemsa, Toluidine Blue and Immunohistochemistry.  
 
Age & Sex distribution of 40 patients presented with gastritis 
TABLE – 2 
Age(years) Male Female Total 
0 TO 20 2(5%) 1(2.5%) 3(7.5%) 
21 TO 40 5(12.5%) 2(5%) 7(17.5%) 
41 TO 60 14(35%) 9(22.5%) 23(57.5%) 
> 60 4(10%) 3(7.5%) 7(17.5%) 
Total 25(62.5%) 15(37.5%) 40(100%) 
 
 Out of 40 patients of gastritis , highest incidence (57.5%) was seen in 
the age group of 41-60 years (23 out of 40) in both males and females which 
is a significant factor. 
 
 Incidence of gastritis shows a male predominance in this study (25 
out of 40 about 62.5%).  
 
 Male:Female sex ratio was about 1.67:1. 
  
Age & Sex distribution of 40 patients presented with gastritis 
CHART -1 
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Age & Sex distribution of 30 patients with gastric adenocarcinoma 
TABLE – 3 
Age(years) Male Female Total 
0 TO 20 0 0 0 
21 TO 40 2(6.7%) 2(6.7%) 4(13.3%) 
41 TO 60 10(33.3%) 4(13.3%) 14(46.7%) 
> 60 11(36.7%) 1(3.3%) 12(40%) 
Total 23(76.7%) 7(23.3%) 30(100%) 
 
 Out of 30 patients with gastric adenocarcinoma highest incidence was 
seen in the age group of 41-60 years  (14 out of 30 about 46.7% ) similar to 
gastritis in this study. 
 On correlation of age with sex ,males show increased incidence in the 
age group of more than 60 years(11 out of 23 about 47.8%). 
 
 Male:Female sex ratio was about 3.3:1 
  
Age & Sex distribution of 30 patients with gastric adenocarcinoma 
CHART -2 
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Sydney scoring in 40 cases of gastritis presented with symptoms 
TABLE – 4 
Sydney 
Score Activity 
Chronic 
Inflammation 
Intestinal 
Metaplasia Atrophy 
Helicobacter 
Pylori 
1 17 18 3 12 10 
2 1 17 0 0 7 
3 0 5 0 0 3 
 
 In this study of 40 cases of gastritis , maximum number of cases in all 
graded variables like activity, chronic inflammation, atrophy, intestinal 
metaplasia and the positivity of Helicobacter Pylori on H&E stain were seen 
in the Sydney score of 1 . 
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Male and Female distribution of positive & negative cases of 
Helicobacter pylori in Gastritis - H&E, Giemsa, Toluidine Blue & IHC 
TABLE – 5 
METHOD 
H&E GIEMSA TOLUIDINE BLUE IHC 
PO
SI
TI
V
E 
N
EG
A
TI
V
E 
PO
SI
TI
V
E 
N
EG
A
TI
V
E 
PO
SI
TI
V
E 
N
EG
A
TI
V
E 
PO
SI
TI
V
E 
N
EG
A
TI
V
E 
MALE(25) 12 13 16 9 15 10 20 5 
FEMALE(15) 8 7 10 5 9 6 10 5 
TOTAL(40) 20 20 26 14 24 16 30 10 
 
Out of 40 cases of gastritis, positivity for H.Pylori was seen in 
20 out of 40 cases (50%) in H& E stain 
26 out of 40 (65%) in Giemsa stain 
24 out of 40 (60%) in Toluidine blue stain 
30 out of 40 cases (75%) in IHC (of which 20 were males and 10 were 
females).  
 The values of which show maximum positivity in IHC. 
  
Male and Female distribution of positive & negative cases of Helicobacter 
pylori in Gastritis - H&E, Giemsa, Toluidine Blue & IHC 
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Male and Female distribution of positive & negative cases of 
Helicobacter pylori in Gastric Adenocarcinoma- H&E, Giemsa, 
Toluidine Blue & IHC 
TABLE – 6 
METHOD 
H&E GIEMSA TOLUIDINE BLUE IHC 
PO
SI
TI
V
E 
N
EG
A
TI
V
E 
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TI
V
E 
N
EG
A
TI
V
E 
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TI
V
E 
N
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A
TI
V
E 
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V
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N
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A
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V
E 
MALE(23) 5 18 13 10 11 12 15 8 
FEMALE(7) 2 5 2 5 2 5 2 5 
TOTAL(30) 7 23 15 15 13 17 17 13 
 
 Out of 30 cases of Gastric adenocarcinoma, positivity for H.Pylori 
was seen in  
7 out of 30 (23%) in H&E stain 
15 out of 30 (50%) in Giemsa stain 
13 out of 30 (43%) in Toluidine blue stain 
17 out of 30 cases (56.6%) in IHC (of which 15 were males and 2 were 
females). 
The maximum number of positivity was seen in IHC similar to gastritis. 
  
Male and Female distribution of positive & negative cases of Helicobacter 
pylori in Gastric Adenocarcinoma- H&E, Giemsa, Toluidine Blue & IHC 
CHART– 5 
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Male & Female ratio of Helicobacter pylori infection in Gastritis Cases 
TABLE – 7 
SEX NO. OF PATIENTS 
H.PYLORI 
POSITIVE 
H.PYLORI 
NEGATIVE 
MALE 25 20(80%) 5(20%) 
FEMALE 15 10(66.6%) 5(33.4%) 
TOTAL 40 30(75%) 10(25%) 
 
 Out of 25 males 20 showed positivity for Helicobacter pylori. The 
percentage of positivity was 80%. 
           Out of 15 females 10 showed positivity for Helicobacter pylori. The 
percentage of positivity was 66.6%. 
              Male : Female ratio was 1.2:1. 
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Male & Female ratio of Helicobacter pylori infection in 30 Gastric 
Adenocarcinoma cases 
TABLE –8 
SEX 
NO. OF 
PATIENTS 
H.PYLORI 
POSITIVE 
H.PYLORI 
NEGATIVE 
MALE 23 15(65.2%) 8(34.8%) 
FEMALE 7 2(28.6%) 5(71.4%) 
TOTAL 30 17(56.6%) 13(43.4%) 
         
          Out of 23 males 15 showed positivity for Helicobacter pylori. The 
percentage of positivity was 65.2%.  
          Out of 7 females 2 showed positivity for Helicobacter pylori. The 
percentage of positivity was 28.6%.  
Male: Female ratio was 2.28:1. 
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Immunohistochemistry results of 40 cases of gastritis for H.pylori 
TABLE –9 
 
 
Helicobacter 
Pylori +ve 
Helicobacter 
Pylori –ve 
No. of Cases 30 10 
Percentage 75% 25% 
 
 Out of 40 cases of gastritis studied for Helicobacter pylori  with IHC 
30 cases showed positivity and 10 cases were negative. The percentage of 
positivity was 75%. 
 
CHART - 8 
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Immunohistochemistry results of 30 cases of gastric  
adenocarcinoma for H.pylori 
TABLE –10 
 
Helicobacter 
Pylori +ve 
Helicobacter Pylori  
–ve 
No. of Cases 17 13 
Percentage 56.6% 43.4% 
 
 Out of 30 cases of gastric adenocarcinoma studied for Helicobacter 
pylori with IHC 17 cases showed positivity and 13 cases were negative. 
The percentage of positivity was 56.6%. 
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Age distribution of Helicobacter pylori infection in 40 cases of Gastritis 
TABLE –11 
AGE(years) TOTAL NEGATIVE POSITIVE 
0 -20 3(7.5%) 0 3(7.5%) 
21-40 7(17.5%) 3(7.5%) 4(10%) 
41-60 23(57.5%) 4(10%) 19(47.5%) 
>60 7(17.5%) 3(7.5%) 4(10%) 
TOTAL 40(100%) 10(25%) 30(75%) 
 
 Out of 40 cases of gastritis studied for Helicobacter pylori with 
immunohistochemistry 30 cases showed positivity. 
          The most common age group affected was seen between 41-60 years. 
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Age distribution of Helicobacter pylori infection in 30 cases of Gastric 
Adenocarcinoma 
TABLE –12 
AGE(years) TOTAL NEGATIVE POSITIVE 
0 -20 0 0 0 
21-40 4(13.3%) 2(6.7%) 2(6.7%) 
41-60 14(46.7%)         6(20%) 8(26.6%) 
>60 12(40%) 5(16.7%) 7(23.3%) 
TOTAL 30(100%) 13(43.4%) 17(56.6%) 
 
 Out of 30 cases of gastric adenocarcinoma studied for Helicobacter 
pylori with immunohistochemistry 17 cases showed positivity. 
          The most common age group affected was seen between 41-60 years. 
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Grading of H.Pylori infection in gastric biopsies using Sydney scoring 
system in various staining methods like H&E, Giemsa, Toluidine Blue 
and IHC  
 
TABLE –13 
STAINING 
METHOD 
TOTAL 
NO. OF 
CASES 
H.PYLORI 
POSITIVE GRADE 1 GRADE 2 GRADE 3 
H.PYLORI 
NEGATIVE 
IHC 40 30(75%) 19(47.5%) 8(20%) 3(7.5%) 10(25%) 
GIEMSA 40 26(65%) 15(37.5%) 8(20%) 3(7.5%) 14(35%) 
TOLUIDINE   
BLUE 
40 24(60%) 13(32.5%) 8(20%) 3(7.5%) 16(40%) 
H&E 40 20(50%) 10(25%) 7(17.5%) 3(7.5%) 20(50%) 
 
 From this table it was shown that detection of Helicobacter pylori 
using H&E, Giemsa, Toluidine blue and IHC was identical in cases of grade 
2 and grade 3 colonisation  of  H.pylori. Differences in staining pattern were 
observed in grade 1 when there is low colonisation of H.pylori. 
 
  
Grading ofH.Pylori infection in Gastric biopsies using Sydney Scoring 
System in various staining methods like H&E, Giemsa, Toluidine Blue 
and IHC 
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Age and Sex distribution among Helicobacter pylori positive Gastritis 
cases by Immunohistochemistry 
 
TABLE –14 
GRADE AND TOTAL 
NUMBER OF CASES 
11 TO 30 31 TO 40 41 TO 50 51 TO 60 61 TO 70 
M
A
LE
 
FE
M
A
LE
 
M
A
LE
 
FE
M
A
LE
 
M
A
LE
 
FE
M
A
LE
 
M
A
LE
 
FE
M
A
LE
 
M
A
LE
 
FE
M
A
LE
 
GRADE 1 (19) 1 1 1 0 3 5 5 0 1 2 
GRADE 2  
(8) 0 1 1 0 1 1 3 0 1 0 
GRADE 3 
(3) 1 0 1 0 0 0 1 0 0 0 
TOTAL (30) 2 2 3 0 4 6 9 0 2 2 
 
 
 From this table it was evident that the most common age group 
infected with Helicobacter pylori was between 41-60 years. 
 
 
  
Age and Sex distribution among Helicobacter pylori positive cases by 
Immunohistochemistry 
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Grading of 30 cases of Gastric Adenocarcinoma 
TABLE –15 
Grade Well Differentiated 
Moderately 
Differentiated 
Poorly 
Differentiated 
No. of Cases 3(10%) 20(67%) 7(23%) 
 
 Out of 30 cases of Gastric adenocarcinoma 3 cases were well 
differentiated, 20 were moderately differentiated, 7 were poorly 
differentiated. 
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Immunohistochemistry results of 30 cases of Gastric Adenocarcinoma 
for Helicobacter Pylori in different grades 
TABLE –16 
GRADE Total No. 
of Cases 
H.Pylori 
Positive 
H.Pylori 
Negative 
Well Differentiated 3 2(66.6%) 1(33.4%) 
Moderately Differentiated 20 11(55%) 9(45%) 
Poorly Differentiated 7 4(57%) 3(43%) 
 
From this table it was evident that out of 30 cases ,17 showed positivity for 
H.pylori.  
 H.pylori positivity was seen in  
2 out of 3(66.6%) cases of well differentiated grade 
11 out of 20 (55%) cases of moderately differentiated grade 
4 out of 7 cases (57%) of poorly differentiated grade 
  
Percentage of cases showing H.Pylori Positivity in different grades of 
Gastric Adenocarcinoma 
CHART – 15 
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COMPARISON OF GIEMSA & IHC IN 40 CASES OF GASTRITIS 
TABLE –17 
GIEMSA 
IHC 
POSITIVE NEGATIVE 
POSITIVE 26 0 
NEGATIVE 4 10 
 
 Out of 40 cases , IHC showed positivity for Helicobacter pylori in 30 
cases.4 cases which were negative by Giemsa stain was found to  be 
positive in IHC. Both Giemsa and IHC showed negativity  in 10 cases. 
Sensitivity - 86.67% 
Specificity - 100% 
Positive Predictive value - 100% 
Negative Predictive value - 71.43% 
% of False Positive - 0.00 
% of False Negative - 13.33 
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COMPARISON OF TOLUIDINE BLUE & IHC IN 40 CASES OF 
GASTRITIS 
TABLE –18 
TOLUIDINE 
BLUE 
IHC 
POSITIVE NEGATIVE 
POSITIVE 24 0 
NEGATIVE 6 10 
 
 Out of 40 cases, IHC showed positivity for Helicobacter pylori in 30 
cases.6 cases which were negative by Toluidine blue stain was found to be 
positive in IHC. Both Toluidine blue and IHC showed negativity in 10 cases 
Sensitivity  - 80% 
Specificity - 100% 
Positive Predictive value - 100% 
Negative Predictive value - 62.50% 
% of False Positive - 0.00 
% of False Negative - 20.00 
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COMPARISON OF H & E & IHC IN 40 CASES OF GASTRITIS 
TABLE –19 
H&E 
IHC 
POSITIVE NEGATIVE 
POSITIVE 20 0 
NEGATIVE 10 10 
 
 Out of 40 cases, IHC showed positivity for Helicobacter pylori in 30 
cases.10 cases which were negative by H&E stain was found to be positive 
in IHC. Both H&E and IHC showed negativity in 10 cases. 
Sensitivity  - 66.67% 
Specificity - 100% 
Positive Predictive value - 100% 
Negative Predictive value - 50% 
% of False Positive - 0.00 
% of False Negative - 33.33 
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COMPARISON OF GIEMSA & IHC IN 30 CASES OF GASTRIC 
ADENOCARCINOMA 
TABLE –20 
GIEMSA 
IHC 
POSITIVE NEGATIVE 
POSITIVE 15 0 
NEGATIVE 2 13 
 
 Out of 30 cases IHC showed positivity for Helicobacter pylori in 17 
cases.2 cases which were negative by Giemsa stain was found to be positive 
in IHC. Both Giemsa and IHC showed negativity in 13 cases. 
Sensitivity  - 88.23% 
Specificity - 100% 
Positive Predictive value - 100% 
Negative Predictive value - 86.67% 
% of False Positive - 0.00 
% of False Negative - 11.76 
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COMPARISON OF TOLUIDINE BLUE & IHC IN 30 CASES OF 
GASTRIC ADENOCARCINOMA 
TABLE – 21 
TOLUIDINE 
BLUE 
IHC 
POSITIVE NEGATIVE 
POSITIVE 13 0 
NEGATIVE 4 13 
 
Out of 30 cases IHC showed positivity for Helicobacter pylori in 17 cases.4 
cases which were negative by Toluidine blue stain was found to be positive 
in IHC. Both Toluidine blue and IHC showed negativity in 13 cases. 
Sensitivity  - 76.47% 
Specificity - 100% 
Positive Predictive value - 100% 
Negative Predictive value - 76.47% 
% of False Positive - 0.00 
% of False Negative - 23.53 
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COMPARISON OF H & E & IHC IN 30 CASES OF GASTRIC 
ADENOCARCINOMA 
TABLE – 22 
H & E 
IHC 
POSITIVE NEGATIVE 
POSITIVE 7 0 
NEGATIVE 10 13 
 
Out of 30 cases IHC showed positivity for Helicobacter pylori in 17cases.10 
cases which were negative by H&E stain was found to be positive in IHC. 
Both H&E and IHC showed negativity in 13 cases 
Sensitivity  - 41.18% 
Specificity - 100% 
Positive Predictive value - 100% 
Negative Predictive value - 56.52% 
% of False Positive - 0.00 
% of False Negative - 58.82 
 
  
 
 
Pictures 
  
Fig. 1 : HPE NO 3423/14 – Adenocarcinoma Stomach 
 
 
 
Fig.2 : Lamina propria with lymphoid follicle formation- H&E (100x) 
 
 
 
Bx 3423/14 
 Fig.3 : Presence of Intraepithelial 
neutrophils- H&E (400
 
 
Fig.5: Intestinal metaplasia in antral 
mucosa- H&E (400
 
 
 
Fig.7 : Helicobacter Pylori c
H&E (400x)
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Fig.4 :Laminapropria inflammation
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Fig.6 : Atrophy of glands
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Fig.8 : Infiltrating adenocarcinoma
stomach- Well differentiated
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 Fig.9 :Infiltrating adenocarcinoma
stomach- Moderately differentiated
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Fig.11 :Helicobacter Pylori colonisation in 
Gastric adenocarcinoma H&E (400x)
 
 
Fig.13 : Helicobacter Pylori  grade 2 
colonisation- Giemsa (4
 
 
- H&E 
 
 
Fig.10 : Infiltrating adenocarcinoma
stomach- Poorly differentiated
(100
 
 
 
Fig.12 :Helicobacter Pylori  grade 1 
colonisation- Giemsa (4
 
 
00x) 
 
Fig.14 : Helicobacter Pylori  grade 3 
colonisation- Giemsa (4
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00x) 
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Fig.15 : Helicobacter Pylori colonisation 
in Gastric adenocarcinoma- Giemsa 
(400x) 
 
 
 
Fig.16: Helicobacter Pylori  grade 1 
colonisation-: Toluidine blue (400x) 
 
 
Fig.17: Helicobacter Pylori  grade 2 
colonisation- Toluidine blue (400x) 
 
 
 
Fig.18: Helicobacter Pylori  grade 3 
colonisation- Toluidine blue (400x) 
 
 
Fig.19 : Helicobacter Pylori colonisation 
in Gastric adenocarcinoma Toluidine blue 
(400x) 
 
 
Fig.20 : Helicobacter Pylori  grade 1 
colonisation- IHC (100x) 
  
Fig.21 : Helicobacter Pylori 
grade 2 colonisation- IHC (100x) 
 
 
 
 
Fig.22 Helicobacter Pylori  grade 3 
colonisation-: IHC (100x) 
 
 
Fig.23 : Helicobacter Pylori colonisation- 
IHC (100x) 
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DISCUSSION 
 
 Helicobacter pylori infection has an important  role in the etiology of 
several diseases of the gastrointestinal tract which  include chronic active 
gastritis, peptic ulcer, Gastric adenocarcinoma and Mucosa - associated 
lymphoid tissue lymphoma. It affects more than 50% of the world wide 
human population. 
 
 In this study to detect the presence of Helicobacter pylori Giemsa, 
Toluidine blue and IHC were done for 40 cases of gastritis and 30 cases of 
gastric adenocarcinoma. 
 
 In a study conducted by Adisa et al [77]   Helicobacter pylori  was 
positive in 345  out of 603 cases and the prevalence rate was about 57.2%. 
 
 In a study conducted by Rajeshkumar et al [79] the Helicobacter 
pylori was positive in 92  out of 265 cases with a prevalence rate of about 
34.71%. 
 
 In a study by Orhan D et al  66 out of 78 cases of antral biopsies 
showed positivity for  Helicobacter pylori  with a prevalence rate of 84.6% 
[130] 
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In a study by  Dr,VishwaPriya.M. Godkhindi et al [131] out of 110 
cases Helicobacter pylori was positive in 69 cases with an overall 
prevalence rate of 62.72%. 
 
 J.E.TZeng, Y.L. Lin, S.M. Chung et al[132] in their study out of 111 
cases, 66 cases showed positivity for Helicobacter pylori  with  a prevalence 
rate of  59.5%. 
 
In the present study of 40 cases of gastritis ,30 cases  were positive 
for  Helicobacter pylori with a prevalence rate of about 75%   and out of 30 
cases of gastric adenocarcinoma 17 cases  showed positivity for 
Helicobacter pylori with a prevalence rate of about 56.6%.. The overall 
prevalence rate was about 67.1%. 
 
Comparison of Helicobacter pylori prevalence with different studies. 
Table-23 
STUDY PREVALENCE  IN ( % ) 
Adisa et al 57.2% 
Rajeshkumar et al 34.71% 
Orhan. D  et al 84.6% 
Vishwapriya M .Godkhindi et al 62.72% 
J.E.TZeng, Y.L .Lin, S.M. Chung, et al 59.5% 
Present study ( 70 cases ) 67.1% 
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The prevalence of Helicobacter pylori infection varies worldwide 
which was more prevalent among developing countries of about 80% seen 
mostly in middle age group and in industrialised countries the prevalence 
rate was about  20-50%. 
 
 Rajeshkumar et al [79] in his prospective study found that the 
maximum  prevalence  of infection with Helicobacter pylori  was in the age 
group of 36-45 years. 
 
 Adisa et al [77] in his study assessed that the prevalence of 
Helicobacter pylori infection was maximum between the age group of 41-50 
years. 
 
 Tanya Dogar et al [133] in his study found that the mean age of 
patients infected with Helicobacter pylori was 45.9 years. 
 
 Javed et al [134] in his study found that the prevalence of 
Helicobacter pylori infection was maximum in the age group of 30 -50 
years. 
 
 In the present study the most common age group affected with 
Helicobacter pylori was seen between 41-60 years in both groups of gastritis 
and gastric adenocarcinoma. 
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Comparison of age groups of persons infected with Helicobacter pylori  
with other studies. 
                                              Table-24 
STUDY Age group 
Rajeshkumar  et al 36-45 years 
Adisa et al 41-50 years 
Tanya Dogar et al Mean Age of 45.9 years 
Javed et al 30 – 50 years 
Present study ( 70 cases ) 41-60 years 
 
The distribution of infection with Helicobacter pylori   varies widely 
among different races, age groups, different population among various 
countries and level of socio economic status. 
 
 Adisa et al [77] in his study found that among the individuals infected 
with Helicobacter pylori 46.8% were males and 53.2% were females. 
 
 In a study by Tanya Dogar et al [133] it was shown that among the 
individuals infected with Helicobacter pylori 59% were males and 41% 
were females. 
 
In a study by Rajeshkumar et al [79] the positivity for Helicobacter 
pylori was seen among 64.13% of males and 35.87 % of females. 
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 In the present study, among 30 H.Pylori positive cases of gastritis  
66.66% were males and 33.34% were females and among 17 H.Pylori 
positive cases of gastric adenocarcinoma  88.2%  were males and 11.8% 
were females. Overall in the study of  total 70 cases 47  showed positivity 
for  Helicobacter pylori. Among these 47 Helicobacter pylori positive cases  
74.5% were males and 25.5% were females. 
 
Comparison of male and female distribution of Helicobacter pylori 
infection with other studies 
Table-25 
Study Males ( in % ) Females (in %) 
Adisa et al 46.8 % 53.2 % 
Tanya Dogar et al 59 % 41 % 
Rajeshkumar et al 64.13 % 35.87 % 
Present study ( 70 cases ) 74.5 % 25.5 % 
 
In a study conducted by Dr.Vishwapriya. M. Godkhindi et al [131] 
among 35 cases of chronic gastritis 32 cases showed positivity (91.42%) for  
Helicobacter pylori and among 14 cases of  Adenocarcinoma (7.14%) 1 
showed positivity for Helicobacter pylori.     
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 In the study by WYatt, JI Semin Diagn pathol [135] Helicobacter 
pylori positivity was seen in 90% of cases of gastritis ad 50% of cases of 
Adenocarcinoma. 
 
 In the present study among 40 cases of gastritis 30 showed positivity 
for Helicobacter pylori (75%) and among 30 cases of gastric 
Adenocarcinoma 17 cases (56.6%) showed  Helicobacter pylori  positivity. 
 
Comparison of frequency of positivity of Helicobacter pylori among 
gastritis and gastric adenocarcinoma with other studies. 
Table-26 
Diseases Present 
study 
Dr.Vishwapriya.M 
Godkhindi et al 
W.YattJI.Semin 
Diagan pathol 
Gastritis 75% 91.42% 90% 
Adenocarcinoma 56.6% 7.14% 50% 
 
 
Helicobacter pylori has an important role in the pathogenesis of upper 
gastrointestinal tract malignancy. So, early detection and eradication of this 
organism is essential for the prevention of gastric cancer. 
 
 Due to lack of contrast between the surrounding tissue and the 
bacteria the H&E stain carries low sensitivity. The  specificity is also low 
due to non specific staining of other bacteria which is seen in the stomach. 
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 Modified Giemsa is a simple, rapid procedure at low cost. It provides 
reliable results with acceptable levels of sensitivity and specificity. 
 
 IHC carries high level of sensitivity and specificity for detection of  
Helicobacter pylori but it is a time consuming technique and also expensive. 
 
In a study by shukla et al[136] for H.Pylori detection among 102 
patients H&E showed sensitivity of about 72.5% and specificity of about 
100%.Giemsa showed sensitivity of about 80.4% and specificity of about 
100%. 
In a study by Pandya et al[137] for H.Pylori among 436 patients it 
was shown that sensitivity of H&E was 100% and specificity was 87.9%. 
Giemsa showed sensitivity of about 100% and specificity of about 84.5%. 
 
In a study among 111 patients for H.Pylori by J.E Tzeng et al[132] 
the sensitivity of H&E was 98.5% and specificity was 100%. Giemsa 
showed sensitivity of about 98.5% and specificity of about 97.8%. 
 
  Raziye Tajalli et al[100] in their study among 54 patients for 
H.Pylori detection found that the sensitivity of H&E was 41.86% and 
specificity was 100%. Giemsa showed sensitivity of about 53.49% and 
specificity of about 95.24%. Toluidine Blue showed sensitivity of about 
76.74% and specificity of about 100%. 
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 In this study for detection of H.Pylori, the sensitivity and specificity 
of various staining methods like H&E, Giemsa, Toluidine Blue and IHC 
were compared. 
 
 In 40 cases of gastritis H&E showed 66.67% sensitivity and 
specificity of about 100%,Giemsa showed 86.67 % sensitivity  and 
specificity of about 100%. Toluidine blue showed 80% sensitivity and 
specificity of about 100% . 
 
In 30 cases of gastric adenocarcinoma H&E showed sensitivity of 
about 41.18% and specificity of about 100%.Giemsa showed sensitivity of 
about 88.23% and specificity of about 100%. Toluidine blue showed 
sensitivity of about 76.47 % and specificity of about 100% . 
 
So in the present study of total 70 cases the overall sensitivity of 
H&E was  57.45% and specificity was about 100% .Giemsa showed  
87.23% sensitivity and 100% specificity , Toluidine blue  showed 78.72% 
sensitivity and 100% Specificity . 
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Comparison of sensitivity and specificity of different stains in the 
present study cases of Gastritis and Gastric Adenocarcinoma 
 
                                                    Table-27 
 
 
Diseases Sensitivity (%) Specificity (%) PPV(%) NPV(%) 
 
H
&
E 
G
 
T.
B 
H
&
E 
G
 
T.
B 
H
&
E 
G
 
T.
B 
H
&
E 
G
 
T.
B 
Gastritis 
(40) 
 
66.67
% 
86.67
% 
80 
% 
100
% 
100
% 
100
% 
100
% 
100
% 
100
% 
50 
% 
71.43
% 
62.5
% 
Gastric 
Adenocarci
noma (30) 
41.18
% 
88.23
% 
76.47
% 
100
% 
100
% 
100
% 
100
% 
100
% 
100
% 
56.52
% 
86.67
% 
76.47
% 
Overall 
results  
( 70 cases ) 
57.45
% 
87.23
% 
78.72
% 
100
% 
100
% 
100
% 
100
% 
100
% 
100
% 
53.49
% 
79.31
% 
69.70
% 
 
• H & E – Hematoxylin - Eosin 
• G – Giemsa 
• T.B – Toluidine Blue 
• PPV – Positive predictive value 
• NPV – Negative Predictive  value 
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Comparison of sensitivity and specificity of different stains in various 
studies 
                                                  Table-28 
Study Sensitivity Specificity PPV NPV 
 
H
&
E 
G
 
T.
B 
H
&
E 
G
 
T.
B 
H
&
E 
G
 
T.
B 
H
&
E 
G
 
T.
B 
Shukla  
et al [136] 72.5% 
80.4
% - 
100
% 100% - 100% 100% - 
78.5
% 
83.6
% - 
Pandya  
et al [137] 100% 100% - 
87.9
% 
84.5
% - 65% 
59.1
% - 100% 100% - 
J.E.Tzeng  
et al [132] 98.5% 
98.5
% - 
100
% 
97.8
% - 100% 
98.5
% - 
97.8
% 
97.8
% - 
Raziye 
Tajalli et 
al [100] 
41.86
% 
53.49
% 
76.74
% 
100
% 
95.24
% 
100
% 
62.07
% 
69.70
% 75% 
69.44
% 
66.6
% 
47.62
% 
Present 
study (70 
Cases ) 
57.45
% 
87.23
% 
78.72
% 
100
% 100% 
100
% 100% 100% 
100
% 
53.49
% 
79.31
% 
69.70
% 
 
• H & E – Hematoxylin - Eosin 
• G – Giemsa 
• T.B – Toluidine Blue 
• PPV – Positive predictive value 
• NPV – Negative Predictive  value 
 
 
 
 
 
Summary 
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SUMMARY  
 
 During the period of July 2013 to June 2014 a total of 150 cases of 
gastritis and 90 cases of gastric adenocarcinoma were received in the  
Institute of Pathology, Madras Medical College, Chennai .Out of this 70 
cases (40 cases of gastritis and 30 cases of gastric adenocarcinoma) were 
selected randomly for this study to detect the presence of Helicobacter 
pylori using Hematoxylin and Eosin, Giemsa, Toluidine Blue and 
Immunohistochemistry.  
 
 In this study the most common age group infected with Helicobacter 
pylori was seen between 41-60 years in both gastritis and gastric 
adenocarcinoma cases. 
 
 In the present study of 40 cases of gastritis, 30 cases were positive for  
Helicobacter pylori with a prevalence rate of about 75% and out of 
30 cases of gastric adenocarcinoma 17 cases  showed positivity for 
Helicobacter pylori with a prevalence rate of about 56.6%.  
 
 In this study of total 70 cases , Helicobacter pylori infection showed 
an overall prevalence rate of about 67.1%.  
 
 Males showed a maximum percentage of positivity in this study. 
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 In this study the maximum percentage of H.Pylori positivity was seen 
in Well differentiated grade of gastric adenocarcinoma. 
 
 From this study it was shown that detection of Helicobacter pylori 
using Hematoxylin & Eosin ,Giemsa, Toluidine blue and 
Immunohistochemistry were identical in cases of grade 2 and grade 3 
colonisation of H.pylori. Differences in staining pattern were 
observed in grade 1 when there is low colonisation of H.pylori , 
where maximum number of cases were detected by 
immunohistochemistry. 
  Hematoxylin and Eosin showed sensitivity of about 57.45% and 
specificity of about 100% . 
  
 Giemsa showed sensitivity of about 87.23% and specificity of about 
100%.  
 
 Toluidine blue showed sensitivity of about 78.72% and specificity of 
about 100%. 
 
 
 
 
 
Conclusion 
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CONCLUSION 
 
 
 In histopathological sections Helicobacter pylori can be identified  by 
various staining methods like Hematoxylin and Eosin (H&E), toluidine 
blue, modified Giemsa, Alcianyellow – toluidine blue, Warthin-starry, 
modified Genta and Immunohistochemistry. Toluidine blue and Giemsa 
methods are inexpensive and reliable. The major disadvantage is little 
contrast between the tissues and the bacteria.  
 
 Immunohistochemistry is the most sensitive technique but it is 
expensive and time consuming. It is not economical to use 
immunohistochemistry in all gastric specimens. It is used in certain specific 
situations like ; 
 
• Low density of organisms 
• To identify coccoid forms 
• In cases of inactive gastritis 
 where the other stains carry low rate of detection for Helicobacter 
pylori.  
 
 The cost, reliability and applicability of Giemsa and Toluidine Blue 
make them as suitable stains for identification of Helicobacter pylori in 
gastric biopsies.  
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 In this study Giemsa stain carries higher level of sensitivity over 
toluidine blue and H&E .Giemsa stain is also a less time consuming 
procedure when compared with IHC. 
 
 Hence in the present study Giemsa was more reliable and cost 
effective stain when compared with Hematoxylin & Eosin, Toluidine blue 
and immunohistochemistry. However, Immunohistochemistry carries the 
highest level of sensitivity in the detection of Helicobacter Pylori especially 
when the density of organism is low and in clinically suspected cases of 
Helicobacter Pylori with negative Giemsa staining. 
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Annexures 
  
ANNEXURE-I 
PROFORMA 
Case number             :                                                  Name      : 
HPE number             :                                                  Age         :  
IP number                 :                                                  Sex         : 
Clinical diagnosis     :  
Complaint                 : 
UGI scopy                 : 
Radioimaging           : 
Specimen                  :  Endoscopic biopsy/others 
GROSS DETAILS   : 
MICROSCOPY       :  Histological diagnosis 
 Special stains for Helicobacter Pylori 
Giemsa                  : Positive/ Negative 
 Toluidine blue        :   Positive/ Negative 
  IHC for H.Pylori    :  Positive/ Negative 
  FINAL IMPRESSION: 
 
 
 
 
  
ANNEXURE-II 
PROFORMA 
Case number             :                                                  Name      : 
HPE number             :                                                  Age         :  
IP number                 :                                                  Sex         : 
Clinical diagnosis     :  
Complaint                 : 
UGI Scopy                : 
Radioimaging           : 
Specimen                  : Subtotal gastrectomy/Total gastrectomy/others. 
GROSS                     
Specimen size          :  Greater curvature                            Lesser curvature 
Tumor size               :                                  
Appearance              : 
Resected margins     : Proximal                                          Distal 
MICROSCOPY       : Histological diagnosis 
Special stains for Helicobacter Pylori 
Giemsa                  :  Positive/ Negative 
 Toluidine blue        :   Positive/ Negative 
  IHC for H.Pylori    :  Positive/ Negative 
  FINAL IMPRESSION: 
 
 
 
 
 
 
 
Master Chart 
 
MASTER CHART 
 

 KEY TO MASTER CHART 
 
H&E  - Hematoxylin and Eosin 
IHC  - Immunohistochemistry 
P  - Positive 
N  - Negative 
H.Pylori - Helicobacter Pylori 
 
SEX 
M  - Male 
F  - Female 
 
GRADE 
W  -  Well differentiated 
M  - Moderately differentiated 
P  - Poorly differentiated 
